Related Experiment Video

Updated: May 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit

María J González1, Alfonso P Gutiérrez, Rosa Gassió

  • 1Neuropediatrics Department, Hospital Universitari Sant Joan de Déu, Barcelona, Spain.

Molecular Genetics and Metabolism
|August 9, 2011
PubMed

Insights

Early diagnosis and consistent dietary management are crucial for phenylketonuria (PKU) patients. Good dietary control significantly improves IQ and reduces neurological and behavioral issues in individuals with PKU.

Area of Science:

  • Metabolic disorders
  • Neurodevelopmental disorders
  • Genetics

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder.
  • Early detection and management are vital for preventing severe health consequences.

Purpose of the Study:

  • To examine the link between neurological complications, behavioral issues, and age at diagnosis in PKU patients.
  • To assess the impact of dietary control on patient outcomes over time.

Main Methods:

  • Retrospective analysis of 121 PKU patients diagnosed and treated between 1985 and 2010.
  • Data collected via a 50-item database from clinical histories, followed by statistical analysis.

Main Results:

  • Early diagnosis (via neonatal screening) correlated with normal IQ (97.7%) and fewer neurological/behavioral problems.
  • Late diagnosis was associated with higher rates of mental retardation (46.3%) and developmental issues.
  • Good dietary control, especially in the first six years, significantly improved IQ and reduced complications (p < 0.0001).

Conclusions:

  • Early diagnosis of PKU is critical for optimal neurodevelopment.
  • Consistent and effective dietary management significantly mitigates neurological and behavioral problems in PKU patients.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...